Our lawyers produce a wealth of substantive, timely and practical guidance and resource materials. Subscribe to receive updates based on your interests.
Life sciences companies are frequent targets of securities litigation. Often, when a company discloses bad news about a developing device or drug, the company’s stock price drops and pl...
Since the SEC staff first decided that a shareholder proposal asking to amend several terms of an existing proxy access bylaw could not be excluded from a proxy statement, which we previo...
On Thursday, December 1, the United States Senate voted 99-0 in favor of the Iran Sanctions Extension Act (H.R. 6297), which renews the Iran Sanctions Act of 1996 (Public Law 104–172; 50 U...
Tax reform will be one of the top priorities for the 115th Congress. Hopes for pursuing tax reform to a successful conclusion are high, given one-party control of the government (and exu...
The composition of boards continues to be a focus for investors, and companies are responding by paying increased attention both to who sits on their boards and to enhancing their disclos...
On December 2, 2016, Comptroller of the Currency Thomas Curry announced the OCC’s proposed framework for granting limited purpose national bank charters to fintechs during an event host...
Today, the House of Representatives passed, by a 254-161 vote, the Systemic Risk Designation Improvement Act of 2016 (the “Act”), which is designed to relieve regional and specialty b...
IN THIS ISSUE:
Introduction
Walking on the cliff edge
New proposals for EU intermediate holding companies
“What’s the model? Have your cake and eat it.”
These were the handwrit...
The advent of a Trump Administration and Republican control of both houses of Congress opens the door to a period of intense debate on U.S. policy toward Iran generally and sanctions reli...
In a recently released white paper, former Small Business Administration head Karen Mills and former Economic Council aide Brayden McCarthy call for regulatory action in the small busines...